Haihui Jiang

Haihui Jiang

Auto-generated profile, based on publicly available information

Haihui Jiang

Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
FGFaliang Gao
Faliang Gao
YCYong Cui
Yong Cui
HJHaihui Jiang
Haihui Jiang
DSDali Sui
Dali Sui
YWYonggang Wang
Yonggang Wang
SLSong Lin
Song Lin
Circulating tumor cell is a common property of brain glioma and promotes the monitoring system

4 December 2023 in Cellular & Molecular Immunology
Verified
Journal Article
Closed access
PDF file
YZYu Zheng
Yu Zheng
HJHaihui Jiang
Haihui Jiang
NYNaixue Yang
Naixue Yang
SSShaoping Shen
Shaoping Shen
DHDaosheng Huang
Daosheng Huang
XLXin Lin
Xin Lin

24 November 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
HJHaihui Jiang
Haihui Jiang
YCYong Cui
Yong Cui
JWJunmei Wang
Junmei Wang
SLSong Lin
Song Lin
Impact of epidemiological characteristics of supratentorial gliomas in adults brought about by the 2016 world health organization classification of tumors of the central nervous system

15 May 2014 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
ZZZhe Zhang
Zhe Zhang
HJHaihui Jiang
Haihui Jiang
XCXuzhu Chen
Xuzhu Chen
JBJiwei Bai
Jiwei Bai
YCYong Cui
Yong Cui
SLSong Lin
Song Lin

13 March 2013 in Neuro-Oncology
Verified
Journal Article
Open access
PDF file
HJHaihui Jiang
Haihui Jiang
XRXiaohui Ren
Xiaohui Ren
XCXiangli Cui
Xiangli Cui
JWJunmei Wang
Junmei Wang
WJWenqing Jia
Wenqing Jia
SLSong Lin
Song Lin
Anaplastic astrocytoma (AA), anaplastic oligoastrocytoma (AOA), and anaplastic oligodendroglioma (AO) are the major histological subtypes of World Health Organization grade III gliomas. More evidence suggests that AOA is unlikely to be a distinct entity, and re-evaluation of this issue has been recommended. In this study, we divided AOA into 2 subgroups, according to molecular biomarkers, and compared the survivals between them. One hundred nine patients with histological diagnosis of anaplastic gliomas enrolled in the study. Molecular biomarkers evaluated included 1p/19q codeletion and IDH1/2 mutation. Kaplan-Meier plots were compared by log-rank method. There was no significant difference between AA and AOA with regard to the frequencies of biomarkers and survival plots. According to the status of biomarkers, AOA was classified into 2 subgroups (AOA1 and AOA2), for which Kaplan-Meier plots were significantly different (P = .001 for both progression-free survival [PFS] and overall survival [OS]). AOA1 with 1p/19q codeletion and/or IDH1/2 mutation showed similar Kaplan-Meier plots with AO (P = .169 for PFS and P = .523 for OS). AOA2 without either biomarker showed similar Kaplan-Meier plots with AA (P = .369 for PFS and P = .271 for OS). In addition, patients with AO and AOA1 had significantly longer PFS and OS than did patients with AA and AOA2 (P < .001 for both PFS and OS). AOA is a heterogeneous group and can be divided into 2 subgroups with significantly different prognoses according to the status of 1p/19q and IDH1/2. This will be helpful in estimating patients' prognosis and guiding reasonable therapy for patients with anaplastic gliomas.

30 May 2014 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
YCYong Cui
Yong Cui
LMLi Ma
Li Ma
XCXuzhu Chen
Xuzhu Chen
ZZZhe Zhang
Zhe Zhang
HJHaihui Jiang
Haihui Jiang
SLSong Lin
Song Lin